You are here: Industry Insights > AstraZeneca

News List

Europe approves SK Bioscience’s global COVID-19 vaccine plant cphi-online
May 27, 2021
CDMO's site becomes the first vaccine production facility in South Korea to obtain EU GMP certification, allowing it to ship to Europe
Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant: Study drugs
May 25, 2021
Two doses of the Pfizer and AstraZeneca COVID-19 vaccines are effective against the coronavirus variant first identified in India, according to a new report from Public Health England.
Bio/pharma industry strives to solve shortage of viral vector used in many COVID-19 vaccines: GlobalData expresspharma
May 25, 2021
Viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities.
AstraZeneca COVID-19 Vaccine Vaxzevria Authorized for Emergency Use in Japan americanpharmaceuticalreview
May 24, 2021
AstraZeneca’s COVID-19 vaccine, Vaxzevria, has been granted special approval for emergency use in Japan for active immunization of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2.
Two AstraZeneca COVID shots 85-90 per cent effective, says UK real-world analysis expresspharma
May 24, 2021
Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine rollouts, generating a lot of data about the use of the shots in real-world settings.
Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective expresspharma
May 20, 2021
The presence of neutralising antibodies rose sevenfold after a Pfizer dose, significantly more than the doubling effect observed after a second AstraZeneca shot.
SK bioscience’s COVID-19 vaccine plant in South Korea gets European nod expresspharma
May 18, 2021
The certification approves the production and processing line and quality system of SK bioscience’s Andong plant, which produces COVID-19 vaccines developed by AstraZeneca Plc and Novavax Inc.
AstraZeneca Shareholders Approve Proposed Acquisition of Alexion americanpharmaceuticalreview
May 12, 2021
A requisite majority of AstraZeneca shareholders has approved the proposal to acquire the entire common stock of Alexion Pharmaceuticals, Inc. (Alexion) at a general meeting.
AZ/Daiichi Sankyo’s datopotamab deruxtecan demonstrates ‘promising’ early results in TNBC pharmatimes
May 11, 2021
AstraZeneca (AZ) and Daiichi Sankyo’s antibody drug conjugate (ACD) datopotamab deruxtecan has demonstrated 'promising' preliminary response and disease control in new data evaluating the therapy among patients with metastatic triple negative breast ...
AZ' Tagrisso first to win MHRA approval under Project Orbis pharmatimes
May 08, 2021
AstraZeneca's Tagrisso (osimertinib), a post-surgery treatment for lung cancer, is the first drug to receive approval from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Project Orbis.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page